TLX:ASX
Telix Pharmaceuticals Ltd
A$16.47
arrow_upward
+1.29%(+0.21) 1D
Sep 4, 4:14:10 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TLX...
Open
A$16.35
High
A$16.66
Low
A$16.26
Mkt. cap
5.60B
Avg. vol.
1.70M
Volume
1.53M
P/E ratio
119.20
52-wk high
A$18.32
52-wk low
A$8.26
EPS
A$0.14
Shares outstanding
339.78M
No. of employees
1K
Open
A$16.35
High
A$16.66
Low
A$16.26
Mkt. cap
5.60B
Avg. vol.
1.70M
Volume
1.53M
P/E ratio
119.20
52-wk high
A$18.32
52-wk low
A$8.26
EPS
A$0.14
Shares outstanding
339.78M
No. of employees
1K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent
TheBull.com.au
·
2 days ago
Telix Pharmaceuticals Shares React To Phase 3 Milestone
MarketBeat
·
2 days ago
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - What's Next?
Investing.com
·
2 days ago
H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on trial completion
About Telix Pharmaceuticals Ltd
CEOChristian Behrenbruch
Employees1.15K
Founded2015
Headquarters-
SectorBiotechnology
Websitetelixpharma.com